{"id":1853,"date":"2001-05-01T12:09:00","date_gmt":"2001-05-01T10:09:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/leserbrief-wirkungsaequivalente-dosierungen-der-protonenpumpen-inhibitoren"},"modified":"2022-03-17T14:09:50","modified_gmt":"2022-03-17T13:09:50","slug":"leserbrief-wirkungsaequivalente-dosierungen-der-protonenpumpen-inhibitoren","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/leserbrief-wirkungsaequivalente-dosierungen-der-protonenpumpen-inhibitoren","title":{"rendered":"Leserbrief: Wirkungs\u00e4quivalente Dosierungen der Protonenpumpen-Inhibitoren"},"content":{"rendered":"<p>Frage von Dr. W. G. aus Hamburg: >> Wie hoch sind die \u00c4quivalenzdosen der in Deutschland erh\u00e4ltlichen Protonenpumpen-Hemmer? > Zur Zeit sind in Deutschland f\u00fcnf Protonenpumpen-Inhibitoren (PPI) zugelassen: Omeprazol (Antra MUPS und viele Generika), Lansoprazol (Agopton, Lanzor), Pantoprazol (Pantozol, Rifun), Rabeprazol (Pariet) und Esomeprazol (Nexium mups). Sie alle sind Benzimidazol-Derivate und unterscheiden sich nicht wesentlich [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von Dr. W. G. aus Hamburg: >> Wie hoch sind die \u00c4quivalenzdosen der in Deutschland erh\u00e4ltlichen Protonenpumpen-Hemmer? > Zur Zeit sind in Deutschland f\u00fcnf Protonenpumpen-Inhibitoren (PPI) zugelassen: Omeprazol (Antra MUPS und viele Generika), Lansoprazol (Agopton, Lanzor), Pantoprazol (Pantozol, Rifun), Rabeprazol (Pariet) und Esomeprazol (Nexium mups). Sie alle sind Benzimidazol-Derivate und unterscheiden sich nicht wesentlich [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1032,113,292,111,291,115,114,1030,3680],"class_list":["post-1853","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-esomeprazol","tag-helicobacter-pylori","tag-lansoprazol","tag-omeprazol","tag-pantoprazol","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-rabeprazol","tag-refluxoesophagitis"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1853"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1853\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}